Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2001

View Archived Issues

Simvastatin's protective effects against vascular disease explored

Orion product update reported

Isis and Merck & Co. extend HCV collaboration

Genzyme General and Diacrin review preliminary phase II results for NeuroCell-PD

Lorus receives FDA approval to evaluate antisense compound in phase I

Amylin licenses novel use of exendin-4 from NIH

Cardioprotective effects demonstrated for ATL-146e in dog model by U. of Virginia team

First in three-part series of webcasts from 50th Scientific Session of the ACC now available

University of Pittsburgh begins second phase of study with LBS-neurons

Attenuation of myocardial I/R injury achieved with LXR-1035 in cell culture and in rats

Combined roxifiban/Innohep has improved safety/efficacy ratio

Symbollon's IoGen shows efficacy in phase II for fibrocystic breast disease

Antithrombotic action of DX-9065a and enoxaparin compared

Inhibition of early apoptosis may prevent subsequent cell proliferation following balloon injury

vWF MAb inhibits stent thrombosis at high shear rates

IAVI and Therion Biologics to develop subtype C AIDS vaccines for India

rPSGL-Ig inhibits in-stent restenosis in angioplasty-injured porcine coronary arteries

Corgentech's E2F decoy granted fast track designation by FDA

Encouraging preliminary results from pivotal trial of first i.v. dual endothelin antagonist in AHF

Connetics to acquire Soltec

Selective RARgamma agonists claimed by Roche for use in emphysema

Tricyclic glycine transport inhibitors and potential uses thereof described in recent patent

Potent, selective inhibitors of GSK-3 in development at GlaxoSmithKline for diabetes, etc.

Cell adhesion inhibitors with antiinflammatory, antiallergic effects reported by Toray

Pharmacia presents new oxazinocarbazoles as ligands for 5-ht6 receptors

Orally available antiproliferative imidazoles under study at Abbott for use in cancer

Cytotoxic compounds emerge from research program at U. Barcelona

New cysteine protease inhibitors with broad application disclosed by Naeja

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.